Comparison of generic and specific anxiety in patients treated with apalutamide plus active surveillance vs active surveillance alone for low and intermediate risk prostate cancer. - Archive ouverte HAL Accéder directement au contenu
Communication Dans Un Congrès Année : 2023

Comparison of generic and specific anxiety in patients treated with apalutamide plus active surveillance vs active surveillance alone for low and intermediate risk prostate cancer.

Sebastien Vincendeau
  • Fonction : Auteur
Sebastien Crouzet
Fichier non déposé

Dates et versions

hal-04228350 , version 1 (04-10-2023)

Identifiants

Citer

Gwenaelle Gravis, Rajae Touzani, Jochen Walz, Guillaume Ploussard, Pierre-Henri Savoie, et al.. Comparison of generic and specific anxiety in patients treated with apalutamide plus active surveillance vs active surveillance alone for low and intermediate risk prostate cancer.. 2023 ASCO Annual Meeting, Jun 2023, Chicago, United States. ⟨10.1200/JCO.2023.41.16_suppl.e17093⟩. ⟨hal-04228350⟩
16 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More